Generalized Lipodystrophy
📧 Sign up to get email alerts when something new happens for Generalized Lipodystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy [Phase 3]
Compassionate-use update for metreleptin in people with generalized lipodystrophy in a Phase 3 program that remains active but not recruitin…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling
Regeneron announced expanded access to REGN4461 for patients with diseases tied to deficient leptin signaling, including lipodystrophy and m…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy [Phase 3]
Open-label Phase 3 trial evaluating metreleptin in children under 6 with generalized lipodystrophy; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: MEASuRE: Metreleptin Effectiveness And Safety Registry
MEASuRE is a registry studying the effectiveness and safety of metreleptin for generalized lipodystrophy and partial lipodystrophy. The stud…